ArticleChemical science2020
Open access · diamondAbstract read
In one paragraph
Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 29 citations in OpenAlex.
- Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma.Molecular oncology · 2026Article
- Mass spectrometry imaging tutorial: From cancer biomarker discovery to clinical applications.Analytica chimica acta · 2026Review
- Picosecond infrared laser mass spectrometry for 10-second identification of lymphoproliferative imposter tumours in patient-derived xenografts.Scientific reports · 2026Article
- A molecular array for 10-second diagnosis of common spinal tumor types with picosecond infrared laser mass spectrometry.Neuro-oncology · 2025Article
- Testing of rapid evaporative mass spectrometry for histological tissue classification and molecular diagnostics in a multi-site study.British journal of cancer · 2024Article
- Reflection mode polarimetry guides laser mass spectrometry to diagnostically important regions of human breast cancer tissue.Scientific reports · 2024Article
- Frontiers in Mass Spectrometry-Based Spatial Metabolomics: Current Applications and Challenges in the Context of Biomedical Research.Trends in analytical chemistry : TRAC · 2024Article
- A Workflow for Meaningful Interpretation of Classification Results from Handheld Ambient Mass Spectrometry Analysis Probes.International journal of molecular sciences · 2024Review
- AI-assisted mass spectrometry imaging withChemical science · 2024Article
- Lipidomic-Based Approach to 10 s Classification of Major Pediatric Brain Cancer Types with Picosecond Infrared Laser Mass Spectrometry.Analytical chemistry · 2024Article
- Lipidome Analysis of Oropharyngeal Tumor Tissues Using Nanosecond Infrared Laser (NIRL) Tissue Sampling and Subsequent Mass Spectrometry.International journal of molecular sciences · 2023Article
- Recent advances in on-site mass spectrometry analysis for clinical applications.Trends in analytical chemistry : TRAC · 2022Review
- Metabolic profiles of human brain parenchyma and glioma for rapid tissue diagnosis by targeted desorption electrospray ionization mass spectrometry.Analytical and bioanalytical chemistry · 2021Article
- Biological Applications for LC-MS-Based Proteomics.Advances in experimental medicine and biology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 3 institutions in 3 countries.
Michael WoolmanTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
Jimmy QiuTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
Claudia M Kuzan-FischerPeter Gilgan Centre for Research and Learning, Hospital for Sick Children 686 Bay Street Toronto ON M5G 0A4 Canada.
Isabelle FerryPeter Gilgan Centre for Research and Learning, Hospital for Sick Children 686 Bay Street Toronto ON M5G 0A4 Canada.
Delaram DaraTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
Lauren KatzTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
Fowad DaudTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
Megan WuPeter Gilgan Centre for Research and Learning, Hospital for Sick Children 686 Bay Street Toronto ON M5G 0A4 Canada.
Manuela VenturaTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
Nicholas BernardsTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
Harley ChanTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
Inga FrickeTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.ORCID https://orcid.org/0000-0002-8386-3375
Mark ZaidiTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
Brad G WoutersTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
James T RutkaPeter Gilgan Centre for Research and Learning, Hospital for Sick Children 686 Bay Street Toronto ON M5G 0A4 Canada.
Sunit DasPeter Gilgan Centre for Research and Learning, Hospital for Sick Children 686 Bay Street Toronto ON M5G 0A4 Canada.
Jonathan IrishTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
Robert WeersinkTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
Howard J GinsbergTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
David A JaffrayTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.
Arash Zarrine-AfsarTechna Institute for the Advancement of Technology for Health, University Health Network 100 College Street, Room 7-207, MaRS Building, Princess Margaret Cancer Research Tower, 7th floor (STTARR) Toronto ON M5G 1P5 Canada arash.zarrine.afsar@utoronto.ca +1-416-581-8473.ORCID https://orcid.org/0000-0002-8013-6893
University Health Network · CAToronto Public Health · CASt. Michael's Hospital · CA
Funding
No grant is acknowledged in the PubMed record.
Abstract
Integration between a hand-held mass spectrometry desorption probe based on picosecond infrared laser technology (PIRL-MS) and an optical surgical tracking system demonstrates
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.